Stock Analiz

Exascale Labs Holdings Inc. XLAB

Computer Software: Prepackaged Software · data as of November 13, 2026

$2.14Market cap $138M
Open the interactive analysis →

Exascale Labs Holdings Inc. (XLAB) is a technology company listed in the US with a market value of about $138M. In fiscal year 2026 it had revenue of $15M and net income of -$12M, a net margin of -82.1%.

Its overall Stock Analiz score is 1.6 out of 5 (weak). The strongest part is future growth (3/5); the weakest is value (0/5).

A discounted cash flow model with moderate assumptions puts its intrinsic value about 66% below the current price.

About Exascale Labs

Exascale Labs is listed in the US and classified in computer software: prepackaged software. It was profitable in 0 of the last 2 years in our data. It spends 37% of revenue on research and development.

Score: 1.6 / 5

Value0/5
Future growth3/5
Track record1/5
Financial health3/5
Shareholder returns1/5

Checks passed

  • Revenue growth above 10% last year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • ROE above 15%
  • More cash than debt, or low debt to equity
  • Interest covered more than 5 times
  • Debt below 3 years of free cash flow
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S9.3
P/B—
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield—
Shareholder yield0.0%
Intrinsic value vs. price−66%

Growth and quality

Revenue growth (1 yr)111.3%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-95.6%
ROIC (5-yr avg.)—
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 2 years

Fiscal year20262025
Revenue$15M$7M
Net income-$12M-$8M
Free cash flow—-$1M
EPS (diluted)$-8108.26$-5106.44
Net margin-82.0%-109.2%
ROIC——

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Exascale Labs stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 66% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Exascale Labs pay a dividend?

Not currently.

Is Exascale Labs a good stock to buy?

We do not give buy or sell advice. Exascale Labs scores 1.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.